Hubei Jumpcan Operating Margin vs. Total Debt
| 600566 Stock | 29.84 1.33 4.67% |
For Hubei Jumpcan profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hubei Jumpcan to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hubei Jumpcan Pharmaceutical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hubei Jumpcan's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hubei Jumpcan Pharmaceutical over time as well as its relative position and ranking within its peers.
Hubei |
Hubei Jumpcan Pharma Total Debt vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Hubei Jumpcan's current stock value. Our valuation model uses many indicators to compare Hubei Jumpcan value to that of its competitors to determine the firm's financial worth. Hubei Jumpcan Pharmaceutical is number one stock in operating margin category among its peers. It also is the top company in total debt category among its peers making up about 3,114,593,813 of Total Debt per Operating Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Hubei Jumpcan by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hubei Jumpcan's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Hubei Total Debt vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Hubei Jumpcan |
| = | 0.33 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Hubei Jumpcan |
| = | 1.04 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Hubei Total Debt vs Competition
Hubei Jumpcan Pharmaceutical is the top company in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 5.51 Billion. Hubei Jumpcan retains roughly 1.04 Billion in total debt claiming about 19% of equities under Health Care industry.
Hubei Jumpcan Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Hubei Jumpcan, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hubei Jumpcan will eventually generate negative long term returns. The profitability progress is the general direction of Hubei Jumpcan's change in net profit over the period of time. It can combine multiple indicators of Hubei Jumpcan, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 2.9 B | 3 B | |
| Income Before Tax | 3.3 B | 3.5 B | |
| Net Income Applicable To Common Shares | 2.5 B | 2.6 B | |
| Net Income | 2.8 B | 3 B | |
| Income Tax Expense | 386.6 M | 406 M | |
| Net Income From Continuing Ops | 2.8 B | 1.7 B | |
| Total Other Income Expense Net | 104.2 M | 87.3 M | |
| Net Interest Income | 257.5 M | 270.4 M | |
| Interest Income | 276.1 M | 289.9 M | |
| Change To Netincome | 3.8 M | 4 M |
Hubei Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Hubei Jumpcan. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hubei Jumpcan position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hubei Jumpcan's important profitability drivers and their relationship over time.
Use Hubei Jumpcan in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hubei Jumpcan position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hubei Jumpcan will appreciate offsetting losses from the drop in the long position's value.Hubei Jumpcan Pair Trading
Hubei Jumpcan Pharmaceutical Pair Trading Analysis
The ability to find closely correlated positions to Hubei Jumpcan could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hubei Jumpcan when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hubei Jumpcan - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hubei Jumpcan Pharmaceutical to buy it.
The correlation of Hubei Jumpcan is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hubei Jumpcan moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hubei Jumpcan Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hubei Jumpcan can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Hubei Jumpcan position
In addition to having Hubei Jumpcan in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Technology Thematic Idea Now
Technology
Companies that are involved in development or distribution of technologically based goods and services such as software, IT or electronics. The Technology theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Technology Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Hubei Stock
To fully project Hubei Jumpcan's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Hubei Jumpcan Pharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Hubei Jumpcan's income statement, its balance sheet, and the statement of cash flows.